Picture of Shin Nippon Biomedical Laboratories logo

2395 — Shin Nippon Biomedical Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Table: Shin Nippon Biomedical -9-MTH group results

Feb 12 (Reuters)-  
             Shin Nippon Biomedical Laboratories Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2015        Dec 31, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             10.42               12.62            14.85     
                 (-17.4 pct)         (+9.9 pct)       (-16.7 pct)  
  Operating       loss 3.27         loss 923 mln       loss 3.90   
  Recurring       loss 3.89            77 mln          loss 4.65   
  Net                2.68           loss 762 mln          2.40     
  EPS             67.47 yen        loss 19.16 yen      60.33 yen   
  Ann Div                                NIL                       
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL                       
   
  NOTE - Shin Nippon Biomedical Laboratories Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Shin Nippon Biomedical Laboratories

See all news